It follows that decoding the precise relationship between aging and ALS could allow to understand whether the effects of aging, including OS, might be a prerequisite to developing the MN disease [326]
What to realistically expect in 36 months Human clinical trials showing benefit typically ran for several months
However, the evidence provided by these studies is only suggestive, and has yet to definitively prove the direct association between the reduction of Lp(a) by PCSK9 inhibitors and cardiovascular risk
Reputable platforms document initial consultation depth, follow-up frequency, and monitoring protocols for adverse effects like nausea, pancreatitis risk markers, or gallbladder concerns
[7] Ainsworth EA, Lemonnier P & Wedow JM (2020)